Sensory therapy for Alzheimer's disease and dementia focuses on engaging the senses to improve well-being and quality of life. This therapy uses various stimuli such as music, aromatherapy, tactile objects, and visual aids to evoke positive emotions, reduce agitation, and enhance cognitive function. For instance, soothing music can trigger memories and calm anxiety, while fragrances like lavender can promote relaxation. Tactile activities such as handling textured objects or using sensory boards stimulate cognitive abilities and encourage social interaction. Visual aids like photo albums or artwork can evoke reminiscence and aid in communication. Overall, sensory therapy offers non-pharmacological support, enhancing the daily lives of individuals with Alzheimer's by providing meaningful and enjoyable experiences that promote connection and comfort.
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States